Non-caloric sweeteners and methods for synthesizing

US11453692B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11453692-B2
Application numberUS-202016799522-A
CountryUS
Kind codeB2
Filing dateFeb 24, 2020
Priority dateOct 3, 2014
Publication dateSep 27, 2022
Grant dateSep 27, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside (Reb W).

First claim

Opening claim text (preview).

What is claimed is: 1. A method for synthesizing rebaudioside E from rebaudioside KA, the method comprising: (i) preparing a reaction mixture comprising (a) at least one of rebaudioside KA and stevioside, (b) substrates selected from the group consisting of sucrose, uridine diphosphate (UDP) and uridine diphosphate-glucose (UDP-glucose), and (c) a UDP-glycosyltransferase fusion enzyme comprising an amino acid sequence having at least 90% identity to SEQ ID NO: 11; (ii) incubating the reaction mixture for a sufficient time to produce rebaudioside E, wherein a glucose is covalently coupled to the C2′-13-O-glucose of rebaudioside KA to produce rebaudioside E. 2. The method of claim 1 , wherein the reaction mixture comprises sucrose and UDP. 3. The method of claim 2 , wherein UDP-glucose is generated from sucrose and UDP present in the reaction mixture by the UDP-glycosyltransferase fusion enzyme. 4. The method of claim 1 , wherein the UDP-glycosyltransferase fusion enzyme comprises an amino acid sequence having at least 95% identity to SEQ ID NO: 11. 5. The method of claim 1 , wherein the UDP-glycosyltransferase fusion enzyme is expressed in a host organism. 6. The method of claim 5 , wherein the host organism is a bacterial cell. 7. The method of claim 5 , wherein the host organism is a yeast cell. 8. The method of claim 5 , wherein the host organism is an E. coli cell. 9. A method for synthesizing rebaudioside E from rubusoside, the method comprising: (i) preparing a reaction mixture comprising (a) rubusoside, (b) substrates selected from the group consisting of sucrose, uridine diphosphate (UDP) and uridine diphosphate-glucose (UDP-glucose), and (c) a UDP-glycosyltransferase fusion enzyme comprising an amino acid sequence having at least 90% identity to SEQ ID NO: 11; (ii) incubating the reaction mixture for a sufficient time to produce rebaudioside E, wherein a glucose is covalently coupled to rubusoside to produce rebaudioside KA or stevioside, and a glucose is covalently coupled to rebausiode KA or stevioside to produce rebaudioside E. 10. The method of claim 9 , wherein the reaction mixture comprises sucrose and UDP. 11. The method of claim 10 , wherein UDP-glucose is generated from sucrose and UDP present in the reaction mixture by the UDP-glycosyltransferase fusion enzyme. 12. The method of claim 9 , wherein the UDP-glycosyltransferase fusion enzyme comprises an amino acid sequence having at least 95% identity to SEQ ID NO: 11. 13. The method of claim 9 , wherein the UDP-glycosyltransferase fusion enzyme is expressed in a host organism. 14. The method of claim 13 , wherein the host organism is a bacterial cell. 15. The method of claim 13 , wherein the host organism is a yeast cell. 16. The method of claim 13 , wherein the host organism is an E. coli cell. 17. The method of claim 1 , wherein the UDP-glycosyltransferase fusion enzyme comprises the amino acid sequence of SEQ ID NO: 11. 18. The method of claim 9 , wherein the UDP-glycosyltransferase fusion enzyme comprises the amino acid sequence of SEQ ID NO: 11.

Assignees

Inventors

Classifications

  • Sucrose synthase (2.4.1.13) · CPC title

  • Fusion polypeptide · CPC title

  • Processes for the preparation of sugar derivatives · CPC title

  • Sweeteners · CPC title

  • Hexosyltransferases (2.4.1) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11453692B2 cover?
Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside (Reb W).
Who is the assignee on this patent?
Conagen Inc
What technology area does this patent fall under?
Primary CPC classification C07H15/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).